Rising burden of enterococcal bacteremia in Victoria, Australia: population-based incidence and antimicrobial resistance trends from three decades of surveillance

Read full text
Authors: Marwa Talat Alhothali, Torsten Seemann, Patiyan Andersson, Norelle Sherry, Jeremy D. Silver, Oscar C. Howden, Mathilda Wilmot, Wendy Siryj, Mark Veitch, Benjamin P. Howden, Courtney R. Lane
Cited by: 4
References: 38

Abstract

ABSTRACT Enterococcal bacteremia is a common healthcare-associated infection, associated with significant morbidity and mortality, with the emergence of vancomycin-resistant enterococci further complicating treatment and clinical outcomes. Despite this, long-term estimates of population-based incidence and antimicrobial resistance trends are limited. We aim to describe the burden of enterococcal bacteremia in Victoria, Australia (population 7.0 million), over a 35-year period. We conducted a retrospective analysis of laboratory-confirmed enterococcal bacteremia episodes voluntarily reported to the Victorian Hospital Pathogen Surveillance Scheme database from 1988 to 2022. Population-based incidence was estimated using inverse probability weighting to adjust for inconsistent hospital participation. Incidence per 10,000 hospital admissions was determined for the period 2011–2022. Antimicrobial resistance was calculated as the annual proportion of resistant isolates among all tested isolates. Overall, 11,157 enterococcal bacteremia episodes were identified, mainly Enterococcus faecalis ( n = 6,915, 61.9%) and Enterococcus faecium ( n = 3,558, 31.9%). Incidence increased from 10 by 2022. Incidence per 10,000 hospital admissions within Victoria has also increased from 2.8 in 2011 to 4 in 2022. Although E. faecalis remained mostly susceptible to tested antibiotics, E. faecium showed persistently high levels of vancomycin resistance, ranging from 50.7% ( n = 69/136) to 66.5% ( n = 139/209) over the past decade. Increasing incidence and high rates of vancomycin resistance among E. faecium highlight the ongoing clinical and public health challenge posed by enterococcal bacteremia. Applying statistical modeling to account for variability in hospital participation improves the certainty of incidence measures and strengthens the evidence for true increase in disease burden.

Fields of Study & Subjects

Antimicrobial Resistance in Staphylococcus Antibiotic Use and Resistance Surgical site infection prevention

Publication details

Journal / source
Antimicrobial Agents and Chemotherapy
Publisher
American Society for Microbiology
Volume
70
Issue
3
Pages
e0152625–e0152625
Publication date
4 February 2026
Language
EN